FDA Official Proposes Changes to Vaccine Approval Process Amid Claims

Nov 30, 2025, 7:24 PM
Image for article FDA Official Proposes Changes to Vaccine Approval Process Amid Claims

Hover over text to view sources

A senior official at the Food and Drug Administration (FDA) has proposed significant changes to the vaccine approval process, alleging that Covid-19 vaccinations have resulted in the deaths of 10 children. Dr Vinay Prasad, the FDA's chief medical and scientific officer, made these claims in an internal memo obtained by CNN, stating that "healthy young children who faced tremendously low risk of death were coerced" into receiving the vaccine through mandates from the Biden administration.
Prasad's memo did not provide specific details regarding the deaths or the methodology behind the FDA's conclusions, but he referenced "an initial analysis" that examined 96 deaths and linked 10 to Covid-19 vaccination. He argued that Covid-19 was never highly lethal for children, comparing its effects to those of other respiratory viruses that do not have annual vaccines.
In light of this analysis, Prasad indicated that the FDA would implement a new approval process requiring more rigorous evidence of safety and efficacy before vaccines can be marketed. This includes stricter requirements for vaccines intended for pregnant women and trials for pneumonia vaccines that must demonstrate a reduction in disease rather than simply producing adequate antibodies.
The proposed changes could lead to longer study durations, potentially delaying vaccine availability. Prasad expressed a willingness to discuss these changes internally, urging staff who disagree with the new principles to resign.
This initiative aligns with the views of Health and Human Services Secretary Robert F. Kennedy Jr, a long-time critic of vaccines who has previously questioned their effectiveness and safety. Kennedy has taken steps to limit access to Covid-19 vaccines, particularly for healthy children and pregnant women, and has reshaped the CDC's advisory committee to include members with similar views.
The FDA is expected to present data linking Covid vaccines to 25 deaths in children at an upcoming meeting of the Advisory Committee on Immunization Practices (ACIP), which plays a crucial role in determining vaccine access and recommendations. However, experts have raised concerns about the validity of claims based on the Vaccine Adverse Event Reporting System (VAERS), which collects unverified reports of adverse events linked to vaccines.
Critics argue that VAERS data cannot definitively prove causation, as it requires comprehensive studies to establish a direct link between vaccination and adverse outcomes. Despite the ongoing investigations, numerous studies have shown that Covid vaccines are safe for children and significantly reduce the risk of hospitalization and death.
FDA Commissioner Marty Makary has stated that the agency is conducting an "intense investigation" into the reported deaths, but he has not provided specific data linking these fatalities to the vaccine. The FDA plans to release a report in the coming weeks, which may clarify the agency's findings.
In the meantime, the FDA recently approved updated Covid-19 vaccines but limited their use to individuals with high-risk health conditions, such as asthma or obesity, while revoking emergency authorization for Pfizer's vaccine for children under 5 years old. This decision has raised concerns among medical professionals and parents who fear it may create barriers to vaccination for many children.
The evolving landscape of vaccine policy, marked by heightened skepticism and calls for stricter regulations, reflects a significant shift in the US approach to immunization during the pandemic. As the FDA and CDC navigate these changes, the implications for public health and vaccine accessibility remain to be seen.
The ongoing debate over vaccine safety and efficacy underscores the importance of transparent communication and rigorous scientific investigation in addressing public concerns about immunization, particularly for vulnerable populations such as children.
In conclusion, the FDA's proposed changes to the vaccine approval process, driven by claims of adverse effects from Covid-19 vaccinations, signal a pivotal moment in US public health policy. The outcomes of these discussions will likely have lasting impacts on vaccine accessibility and public trust in immunization programs.

Related articles

Federal Government Sues Advocate Aurora Health Over Vaccine Policy

The US Equal Employment Opportunity Commission has filed a lawsuit against Advocate Aurora Health, alleging the health system discriminated against a nurse by denying her a religious exemption from the COVID-19 vaccine mandate. The lawsuit seeks reinstatement, back pay, and changes to the health system's policies.

Kennedy Plans Overhaul of Childhood Vaccine Schedule

Health Secretary Robert F. Kennedy Jr is set to announce a significant overhaul of the childhood vaccination schedule in the US, proposing fewer vaccines in alignment with countries like Denmark. This change has raised concerns among medical experts about potential public health risks and the implications for vaccine accessibility.

Trump Announces New Drug Pricing Deals with Nine Companies

President Trump has announced 'Most Favored Nation' pricing agreements with nine pharmaceutical companies aimed at reducing drug costs for Americans. The agreements will allow Medicaid programs to access lower prices and include plans for a meeting with health insurers to discuss lowering premiums.

Reflecting on America's First COVID Vaccine Five Years Later

Five years ago, the US began its vaccination campaign against COVID-19, marking a pivotal moment in public health. The rapid development and distribution of vaccines, particularly the Pfizer-BioNTech vaccine, showcased unprecedented scientific achievement. As the nation reflects on this milestone, it grapples with the ongoing impacts of the pandemic and the evolving perceptions of vaccines.

White House Names RFK Jr. Deputy as CDC Director Replacement

The White House has appointed Jim O'Neill, deputy to Health Secretary Robert F. Kennedy Jr, as acting director of the CDC following Susan Monarez's abrupt removal. The move follows internal turmoil at the agency over vaccine policies and political interference, with multiple senior officials resigning in protest.